• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4640427)   Today's Articles (595)   Subscriber (50377)
For: Sinha A, Nast CC, Hristea I, Vo AA, Jordan SC. Resolution of clinical and pathologic features of C1q nephropathy after rituximab therapy. Clin Exp Nephrol 2010;15:164-70. [PMID: 21107633 DOI: 10.1007/s10157-010-0377-x] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2010] [Accepted: 10/26/2010] [Indexed: 01/22/2023]
Number Cited by Other Article(s)
1
C1q nephropathy in a patient complicated with nephrotic syndrome and refractory to steroid therapy. JOURNAL OF MICROBIOLOGY, IMMUNOLOGY, AND INFECTION = WEI MIAN YU GAN RAN ZA ZHI 2020;53:183-185. [DOI: 10.1016/j.jmii.2019.06.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/29/2018] [Revised: 06/01/2019] [Accepted: 06/06/2019] [Indexed: 11/22/2022]
2
Ma R, Wu D, He Z, Chang Q, Yang Y. Case Report: Complete Remission of C1q Nephropathy Treated With a Single Low-Dose Rituximab, a Reality or Coincidence? Front Pediatr 2020;8:568773. [PMID: 33634050 PMCID: PMC7902059 DOI: 10.3389/fped.2020.568773] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/02/2020] [Accepted: 10/22/2020] [Indexed: 12/22/2022]  Open
3
C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics. PLoS One 2019;14:e0215217. [PMID: 31002691 PMCID: PMC6474651 DOI: 10.1371/journal.pone.0215217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2018] [Accepted: 03/28/2019] [Indexed: 11/24/2022]  Open
4
Varshavsky VA, Grishina AN, Chebotareva NV, Gudkova EI. [The clinical and morphological characteristics of C1q glomerulopathy]. Arkh Patol 2018;80:46-51. [PMID: 29460894 DOI: 10.17116/patol201880146-51] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
5
Ramachandran R, Bharati J, Jha V. Successful treatment of C1q nephropathy with CD19 targeted Rituximab therapy. Nephrology (Carlton) 2017;22:265. [PMID: 28205352 DOI: 10.1111/nep.12757] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2016] [Revised: 02/23/2016] [Accepted: 02/23/2016] [Indexed: 11/28/2022]
6
Yang J, Zhang BL. [Advances in clinical research on C1q nephropathy]. ZHONGGUO DANG DAI ER KE ZA ZHI = CHINESE JOURNAL OF CONTEMPORARY PEDIATRICS 2016. [PMID: 27817791 DOI: 10.7499/j.issn.1008-8830.2016.11.027] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
7
Devasahayam J, Erode-Singaravelu G, Bhat Z, Oliver T, Chandran A, Zeng X, Dakshinesh P, Pillai U. C1q Nephropathy: The Unique Underrecognized Pathological Entity. Anal Cell Pathol (Amst) 2015;2015:490413. [PMID: 26640759 PMCID: PMC4657067 DOI: 10.1155/2015/490413] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2015] [Accepted: 10/08/2015] [Indexed: 11/17/2022]  Open
8
Tibor Fülöp T, Csongrádi É, Lerant AA, Lewin M, Lewin JR. Resolution of C1q deposition but not of the clinical nephrotic syndrome after immunomodulating therapy in focal sclerosis. J Nephropathol 2015;4:54-8. [PMID: 25964890 PMCID: PMC4417671 DOI: 10.12860/jnp.2015.11] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2015] [Accepted: 02/25/2015] [Indexed: 01/10/2023]  Open
9
Malleshappa P, Vankalakunti M. Diverse clinical and histology presentation in c1q nephropathy. Nephrourol Mon 2013;5:787-91. [PMID: 24282787 PMCID: PMC3830903 DOI: 10.5812/numonthly.8308] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2012] [Revised: 10/29/2012] [Accepted: 11/11/2012] [Indexed: 11/16/2022]  Open
10
Ejaz AA, Asmar A, Alsabbagh MM, Ahsan N. Rituximab in immunologic glomerular diseases. MAbs 2012;4:198-207. [PMID: 22377738 PMCID: PMC3361655 DOI: 10.4161/mabs.4.2.19286] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2011] [Revised: 12/26/2011] [Accepted: 01/07/2012] [Indexed: 02/06/2023]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA